STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

MIST MILESTONE PHARMACEUTICALS INCORPORATED StockScouter® Report

4

StockScouter® Score

MILESTONE PHARMACEUTICALS INCORPORATED, a small cap company in the healthcare sector, is expected to slightly underperform the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • An executive, director or major shareholder purchased a large number of shares recently. Postive/Neutral
  • Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a small company like MIST

 

Concerns

  • The most recent quarterly earnings report was slightly lower than analysts’ consensus forecast. Neutral/Negative
  • The 50-day moving average for MIST is below its 200-day moving average. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be in favor, stocks will be , and healthcare stocks will be in favor.

Expected Risk/Return

Progress: 80% done.
Progress: 40% done.
Low
High

Core Model Grades

D
A
N/A
C

Previous Ratings

4
4